Trial Outcomes & Findings for A Comparison of Metallic Staples Versus Absorbable Staples After a Cesarean Section (C-Section) (NCT NCT01198691)

NCT ID: NCT01198691

Last Updated: 2018-10-09

Results Overview

Post operative pain at post operative day #1 will be measured using the Visual Analogue Scale (VAS). The scale has a minimum score of 0 representing no pain and a maximum score of 10 representing the worst possible pain.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

100 participants

Primary outcome timeframe

1 Year

Results posted on

2018-10-09

Participant Flow

Participant milestones

Participant milestones
Measure
Control Group
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Completed Surgery -Received Intervention
STARTED
50
50
Completed Surgery -Received Intervention
COMPLETED
50
50
Completed Surgery -Received Intervention
NOT COMPLETED
0
0
Completed VAS Score Postop Day 1
STARTED
50
50
Completed VAS Score Postop Day 1
COMPLETED
47
46
Completed VAS Score Postop Day 1
NOT COMPLETED
3
4
Completed VAS Score at Discharge
STARTED
50
50
Completed VAS Score at Discharge
COMPLETED
45
44
Completed VAS Score at Discharge
NOT COMPLETED
5
6
Survey Prior to Discharge
STARTED
50
50
Survey Prior to Discharge
COMPLETED
18
17
Survey Prior to Discharge
NOT COMPLETED
32
33
6 Week Post-partum Survey
STARTED
50
50
6 Week Post-partum Survey
COMPLETED
21
26
6 Week Post-partum Survey
NOT COMPLETED
29
24

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Comparison of Metallic Staples Versus Absorbable Staples After a Cesarean Section (C-Section)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=50 Participants
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
n=50 Participants
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Total
n=100 Participants
Total of all reporting groups
Age, Continuous
28.32 years
STANDARD_DEVIATION 5.63 • n=99 Participants
27.38 years
STANDARD_DEVIATION 6.15 • n=107 Participants
27.85 years
STANDARD_DEVIATION 5.89 • n=206 Participants
Sex: Female, Male
Female
50 Participants
n=99 Participants
50 Participants
n=107 Participants
100 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Black/African American
22 participants
n=99 Participants
23 participants
n=107 Participants
45 participants
n=206 Participants
Race/Ethnicity, Customized
White/Caucasian
24 participants
n=99 Participants
26 participants
n=107 Participants
50 participants
n=206 Participants
Race/Ethnicity, Customized
Asian
2 participants
n=99 Participants
0 participants
n=107 Participants
2 participants
n=206 Participants
Race/Ethnicity, Customized
Pacific Islander
2 participants
n=99 Participants
1 participants
n=107 Participants
3 participants
n=206 Participants
Region of Enrollment
United States
50 participants
n=99 Participants
50 participants
n=107 Participants
100 participants
n=206 Participants

PRIMARY outcome

Timeframe: 1 Year

Post operative pain at post operative day #1 will be measured using the Visual Analogue Scale (VAS). The scale has a minimum score of 0 representing no pain and a maximum score of 10 representing the worst possible pain.

Outcome measures

Outcome measures
Measure
Control Group
n=47 Participants
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
n=46 Participants
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Post Operative Pain
2.56 units on a scale
Standard Error 1.47
2.90 units on a scale
Standard Error 1.54

PRIMARY outcome

Timeframe: 1 Year

Post operative pain at the time of discharge will be measured using the Visual Analogue Scale (VAS). The scale has a minimum score of 0 representing no pain and a maximum score of 10 representing the worst possible pain.

Outcome measures

Outcome measures
Measure
Control Group
n=45 Participants
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
n=44 Participants
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Post Operative Pain (3 Days Post-op)
2.66 units on a scale
Standard Deviation 1.47
3.52 units on a scale
Standard Deviation 5.80

SECONDARY outcome

Timeframe: This will be assessed 3 day after the patient's C-section before they are discharged from the hospital

Patients will be given a survey prior to being discharged to assess their satisfaction with the appearance of their scar. The survey asked whether patients "strongly agree," "agree," "disagree," or "strongly disagree" with the statement, "I am satisfied with the overall appearance of my incision." Those who responsed "agree" or "strongly agree" were said to be satisfied with the appearance and the outcome is reported as number of participants who were satisfied.

Outcome measures

Outcome measures
Measure
Control Group
n=18 Participants
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
n=17 Participants
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Patient Satisfaction
16 participants
14 participants

SECONDARY outcome

Timeframe: Patient satisfaction will be assessed 6 weeks later at their post-op visit

Patients will be given a survey at their 6 week post-op visit to assess their satisfaction with the appearance of their scar. The survey asked whether patients "strongly agree," "agree," "disagree," or "strongly disagree" with the statement, "I am satisfied with the overall appearance of my incision." Those who responsed "agree" or "strongly agree" were said to be satisfied with the appearance and the outcome is reported as number of participants who were satisfied.

Outcome measures

Outcome measures
Measure
Control Group
n=21 Participants
This group will receive the standard metallic staples to close their incision. Insorb absorbable staples: Patients will be randomized to receive either the standard metallic staples or the Insorb absorbable staples
Case Group
n=26 Participants
This group will receive the Insorb absorbable staples to close their incision. Insorb: Patients will be randomized to receive either standard metallic staples or Insorb absorbable staples
Patient Satisfaction
20 participants
21 participants

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Case Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Donna Lambers, MD

TriHealth

Phone: 513-862-2828

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place